193 related articles for article (PubMed ID: 9101296)
21. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
[TBL] [Abstract][Full Text] [Related]
22. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive mutation analysis of TSC1 using two-dimensional DNA electrophoresis with DGGE.
Dabora SL; Sigalas I; Hall F; Eng C; Vijg J; Kwiatkowski DJ
Ann Hum Genet; 1998 Nov; 62(Pt 6):491-504. PubMed ID: 10363127
[TBL] [Abstract][Full Text] [Related]
24. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
26. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
27. Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.
Holmila R; Husgafvel-Pursiainen K
Cancer Detect Prev; 2006; 30(1):1-6. PubMed ID: 16458448
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
[TBL] [Abstract][Full Text] [Related]
29. Screening of alpha-1-antitrypsin gene by denaturing gradient gel electrophoresis (DGGE).
Ljujic M; Nikolic A; Divac A; Djordjevic V; Radojkovic D
J Biochem Biophys Methods; 2006 Oct; 68(3):167-73. PubMed ID: 16814390
[TBL] [Abstract][Full Text] [Related]
30. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.
Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F
Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624
[TBL] [Abstract][Full Text] [Related]
31. Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients.
Ouhtit A; Ueda M; Nakazawa H; Ichihashi M; Dumaz N; Sarasin A; Yamasaki H
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):433-8. PubMed ID: 9184777
[TBL] [Abstract][Full Text] [Related]
32. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
33. [Detection of point mutation in p53 gene by capillary electrophoresis-PCR-SSCP analysis].
Liu J; Jing H; Ru Q; Deng Y; Luo G; Huang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):476-9. PubMed ID: 12910694
[TBL] [Abstract][Full Text] [Related]
34. Discordance of p53 mutations of synchronous colorectal carcinomas.
Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
[TBL] [Abstract][Full Text] [Related]
35. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
[TBL] [Abstract][Full Text] [Related]
36. A correlation between mutation of the p53 gene and histological heterogeneity in differentiated adenocarcinomas of the lung, with reference to stepwise progression and metastatic ability.
Yoshida Y
Hiroshima J Med Sci; 1994 Mar; 43(1):13-21. PubMed ID: 8014071
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
39. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
[TBL] [Abstract][Full Text] [Related]
40. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
